AstraZeneca expects U.S. COVID-19 vaccine authorization in April
(Reuters) - AstraZeneca Plc expects its COVID-19 vaccine could receive U.S. Emergency Use Authorization at the beginning of April and could immediately deliver 30 million doses of the shot there, a top executive said at a hearing in the U.S. House of Representatives on Tuesday.
Ruud Dobber, executive vice president at AstraZeneca, said that the drugmaker expects to be able to deliver 50 million doses of the vaccine by the end of April.
(Reporting by Michael Erman)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.